Cargando…

Effectiveness of Combined Therapy with Pirfenidone and Erythromycin for Unclassifiable Interstitial Pneumonia Induced by HTLV-1-associated Bronchioloalveolar Disorder (HABA)

Human T-cell lymphotropic virus type 1 (HTLV-1) is a retrovirus involved in the pathogenesis of adult T-cell leukemia (ATL) and HTVL-1-associated bronchioloalveolar disorder (HABA). The clinical and pathological findings of HABA have been characterized as either a diffuse panbronchiolitis (DPB) patt...

Descripción completa

Detalles Bibliográficos
Autores principales: Yokohori, Naoko, Sato, Akitoshi, Hasegawa, Mizue, Katsura, Hideki, Hiroshima, Kenzo, Takemura, Tamiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5313428/
https://www.ncbi.nlm.nih.gov/pubmed/28050003
_version_ 1782508341522595840
author Yokohori, Naoko
Sato, Akitoshi
Hasegawa, Mizue
Katsura, Hideki
Hiroshima, Kenzo
Takemura, Tamiko
author_facet Yokohori, Naoko
Sato, Akitoshi
Hasegawa, Mizue
Katsura, Hideki
Hiroshima, Kenzo
Takemura, Tamiko
author_sort Yokohori, Naoko
collection PubMed
description Human T-cell lymphotropic virus type 1 (HTLV-1) is a retrovirus involved in the pathogenesis of adult T-cell leukemia (ATL) and HTVL-1-associated bronchioloalveolar disorder (HABA). The clinical and pathological findings of HABA have been characterized as either a diffuse panbronchiolitis (DPB) pattern or idiopathic interstitial pneumonia (IIP) pattern. Treatments for HABA include corticosteroids for the IIP pattern and erythromycin for the DPB pattern. We herein report a case of HABA-associated unclassifiable interstitial pneumonia that improved with combined therapy with pirfenidone and erythromycin. This is the first report on the effectiveness of combined therapy with pirfenidone and erythromycin for HABA.
format Online
Article
Text
id pubmed-5313428
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher The Japanese Society of Internal Medicine
record_format MEDLINE/PubMed
spelling pubmed-53134282017-02-28 Effectiveness of Combined Therapy with Pirfenidone and Erythromycin for Unclassifiable Interstitial Pneumonia Induced by HTLV-1-associated Bronchioloalveolar Disorder (HABA) Yokohori, Naoko Sato, Akitoshi Hasegawa, Mizue Katsura, Hideki Hiroshima, Kenzo Takemura, Tamiko Intern Med Case Report Human T-cell lymphotropic virus type 1 (HTLV-1) is a retrovirus involved in the pathogenesis of adult T-cell leukemia (ATL) and HTVL-1-associated bronchioloalveolar disorder (HABA). The clinical and pathological findings of HABA have been characterized as either a diffuse panbronchiolitis (DPB) pattern or idiopathic interstitial pneumonia (IIP) pattern. Treatments for HABA include corticosteroids for the IIP pattern and erythromycin for the DPB pattern. We herein report a case of HABA-associated unclassifiable interstitial pneumonia that improved with combined therapy with pirfenidone and erythromycin. This is the first report on the effectiveness of combined therapy with pirfenidone and erythromycin for HABA. The Japanese Society of Internal Medicine 2017-01-01 /pmc/articles/PMC5313428/ /pubmed/28050003 Text en https://creativecommons.org/licenses/by-nc-nd/4.0/ The Internal Medicine is an Open Access article distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. To view the details of this license, please visit (https://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Yokohori, Naoko
Sato, Akitoshi
Hasegawa, Mizue
Katsura, Hideki
Hiroshima, Kenzo
Takemura, Tamiko
Effectiveness of Combined Therapy with Pirfenidone and Erythromycin for Unclassifiable Interstitial Pneumonia Induced by HTLV-1-associated Bronchioloalveolar Disorder (HABA)
title Effectiveness of Combined Therapy with Pirfenidone and Erythromycin for Unclassifiable Interstitial Pneumonia Induced by HTLV-1-associated Bronchioloalveolar Disorder (HABA)
title_full Effectiveness of Combined Therapy with Pirfenidone and Erythromycin for Unclassifiable Interstitial Pneumonia Induced by HTLV-1-associated Bronchioloalveolar Disorder (HABA)
title_fullStr Effectiveness of Combined Therapy with Pirfenidone and Erythromycin for Unclassifiable Interstitial Pneumonia Induced by HTLV-1-associated Bronchioloalveolar Disorder (HABA)
title_full_unstemmed Effectiveness of Combined Therapy with Pirfenidone and Erythromycin for Unclassifiable Interstitial Pneumonia Induced by HTLV-1-associated Bronchioloalveolar Disorder (HABA)
title_short Effectiveness of Combined Therapy with Pirfenidone and Erythromycin for Unclassifiable Interstitial Pneumonia Induced by HTLV-1-associated Bronchioloalveolar Disorder (HABA)
title_sort effectiveness of combined therapy with pirfenidone and erythromycin for unclassifiable interstitial pneumonia induced by htlv-1-associated bronchioloalveolar disorder (haba)
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5313428/
https://www.ncbi.nlm.nih.gov/pubmed/28050003
work_keys_str_mv AT yokohorinaoko effectivenessofcombinedtherapywithpirfenidoneanderythromycinforunclassifiableinterstitialpneumoniainducedbyhtlv1associatedbronchioloalveolardisorderhaba
AT satoakitoshi effectivenessofcombinedtherapywithpirfenidoneanderythromycinforunclassifiableinterstitialpneumoniainducedbyhtlv1associatedbronchioloalveolardisorderhaba
AT hasegawamizue effectivenessofcombinedtherapywithpirfenidoneanderythromycinforunclassifiableinterstitialpneumoniainducedbyhtlv1associatedbronchioloalveolardisorderhaba
AT katsurahideki effectivenessofcombinedtherapywithpirfenidoneanderythromycinforunclassifiableinterstitialpneumoniainducedbyhtlv1associatedbronchioloalveolardisorderhaba
AT hiroshimakenzo effectivenessofcombinedtherapywithpirfenidoneanderythromycinforunclassifiableinterstitialpneumoniainducedbyhtlv1associatedbronchioloalveolardisorderhaba
AT takemuratamiko effectivenessofcombinedtherapywithpirfenidoneanderythromycinforunclassifiableinterstitialpneumoniainducedbyhtlv1associatedbronchioloalveolardisorderhaba